ES2185666T3 - Formulacion estabilizada para comprimidos. - Google Patents

Formulacion estabilizada para comprimidos.

Info

Publication number
ES2185666T3
ES2185666T3 ES94927999T ES94927999T ES2185666T3 ES 2185666 T3 ES2185666 T3 ES 2185666T3 ES 94927999 T ES94927999 T ES 94927999T ES 94927999 T ES94927999 T ES 94927999T ES 2185666 T3 ES2185666 T3 ES 2185666T3
Authority
ES
Spain
Prior art keywords
tablets
formulation stabilized
stabilized
invented
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94927999T
Other languages
English (en)
Spanish (es)
Inventor
Patrick Gerard Faulkner
Mark Warren Fisher
Joseph Peter Sauer
Carlos Roberto Hernandez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939318348A external-priority patent/GB9318348D0/en
Priority claimed from GB939323864A external-priority patent/GB9323864D0/en
Priority claimed from GB9411903A external-priority patent/GB9411903D0/en
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of ES2185666T3 publication Critical patent/ES2185666T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES94927999T 1993-09-03 1994-09-02 Formulacion estabilizada para comprimidos. Expired - Lifetime ES2185666T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939318348A GB9318348D0 (en) 1993-09-03 1993-09-03 Stabilized tablet formulation
GB939323864A GB9323864D0 (en) 1993-11-19 1993-11-19 Stabilized tablet formulation
GB9411903A GB9411903D0 (en) 1994-06-14 1994-06-14 Stabilized tablet formulation

Publications (1)

Publication Number Publication Date
ES2185666T3 true ES2185666T3 (es) 2003-05-01

Family

ID=27266839

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94927999T Expired - Lifetime ES2185666T3 (es) 1993-09-03 1994-09-02 Formulacion estabilizada para comprimidos.

Country Status (10)

Country Link
US (2) US5882681A (zh)
EP (1) EP0717618B1 (zh)
JP (1) JPH09504271A (zh)
CN (1) CN1133005A (zh)
AT (1) ATE227122T1 (zh)
AU (1) AU7719894A (zh)
CA (1) CA2170892A1 (zh)
DE (1) DE69431662T2 (zh)
ES (1) ES2185666T3 (zh)
WO (1) WO1995006461A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL115445A (en) * 1994-10-17 1999-08-17 Akzo Nobel Nv Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation
IL123984A (en) 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
PL197077B1 (pl) 1998-12-01 2008-02-29 Reddys Lab Inc Dr Kompozycja farmaceutyczna zawierająca 5-[[4-[3-metylo-4-okso-3,4-dihydro-2-chinazolinylo]metoksy]fenylometylo]-tiazolidyno-2,4-dion lub jego sól dopuszczalną do stosowania w farmacji i sposób jej wytwarzania
JP2004506609A (ja) 2000-05-26 2004-03-04 ノボ　ノルディスク　アクティーゼルスカブ 新たなる医薬組成物及びその調製の為の方法
AU2000249111A1 (en) * 2000-05-30 2001-12-11 Dr. Reddy's Research Foundation New pharmaceutical composition and the process for its preparation
CL2008000596A1 (es) * 2007-03-01 2008-09-05 Glaxo Group Ltd Forma de dosificacion que comprende 1-(6-[(3-ciclobutil-2,3,4,5-tetrahidro-1h-3-benzazepin-7-il)oxi]-3-piridinil)-2-pirrolidinona, un estabilizador, un excipiente; procedimiento de preparacion; y su uso para tratar enfermedades neurologicas.
US20080300855A1 (en) * 2007-05-31 2008-12-04 Alibaig Mohammad Munwar Method for realtime spoken natural language translation and apparatus therefor

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1583749A (en) * 1976-06-03 1981-02-04 Res Inst Medicine Chem Vitamin d derivatives
US4172132A (en) * 1977-07-26 1979-10-23 Schering Corporation 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
US4185101A (en) * 1977-08-11 1980-01-22 Schering Corporation 1,3,5(10),6,8-19-Nor-pregnapentaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
US4473564A (en) * 1983-07-12 1984-09-25 Akzo N.V. 19-Thio-androstane derivatives
EP0187433B1 (en) * 1983-08-01 1990-12-27 Teijin Limited Powdery pharmaceutical composition suitable for application to mucosa of oral or nasal cavity
GB8420771D0 (en) * 1984-08-15 1984-09-19 Efamol Ltd Treatment of skin disorders
ZA883034B (en) * 1987-04-29 1989-03-29 Smithkline Beckman Corp Steroid 5-alpha-reductase inhibitors
GB9006023D0 (en) * 1990-03-16 1990-05-09 Smithkline Beecham Corp Synergistic compositions
US5300294A (en) * 1990-06-27 1994-04-05 Smithkline Beecham Corporation Method of treating prostatic adenocarcinoma
US5091380A (en) * 1990-06-28 1992-02-25 Merck & Co., Inc. N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors
IT1259419B (it) * 1991-05-24 1996-03-18 Erba Carlo Spa Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi
NZ251658A (en) * 1992-04-02 1996-08-27 Smithkline Beecham Corp Medicaments comprising a steroid 5-<alpha>reductase inhibitor, an <alpha>-adrenergic receptor antagonist, and a carrier
ES2105108T3 (es) * 1992-04-20 1997-10-16 Sankyo Co Esteroides para el tratamiento de la hipertrofia prostatica, su preparacion y su utilizacion.

Also Published As

Publication number Publication date
US5882681A (en) 1999-03-16
ATE227122T1 (de) 2002-11-15
AU7719894A (en) 1995-03-22
EP0717618A1 (en) 1996-06-26
DE69431662D1 (de) 2002-12-12
EP0717618B1 (en) 2002-11-06
EP0717618A4 (en) 1997-06-04
CA2170892A1 (en) 1995-03-09
DE69431662T2 (de) 2003-09-18
US5665390A (en) 1997-09-09
WO1995006461A1 (en) 1995-03-09
JPH09504271A (ja) 1997-04-28
CN1133005A (zh) 1996-10-09

Similar Documents

Publication Publication Date Title
IL115790A0 (en) Pharmaceutical compositions containing boronic ester and acid compounds and methods for the preparation thereof
NL980012I2 (nl) Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
EE200000320A (et) Uudsed ühendid
SE9704544D0 (sv) Novel compounds
AU649421B2 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
HUT68963A (en) Novel 4-arylpiperazines and 4-arylpiperidines, pharmaceutical compositions comprising them and the proces for producing thereof
SE9504661D0 (sv) New compounds
ATE216590T1 (de) Arzneimittelformulierungen für il-12
NZ244021A (en) Benzylthiazolidinedione derivatives, preparation and pharmaceutical compositions thereof
PT758248E (pt) Formulacoes para o factor ix
WO1991018866A3 (en) 1,4-diamino-2,3-dihydroxybutanes
TR200200785T2 (tr) 8-Fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-on türevleri
NO965516D0 (no) Sterolderivater anvendt til regulering av meiose
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES2157993T3 (es) Benzoilguanidinas, su preparacion y su uso en medicamentos.
IS1565B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
NO921382D0 (no) Amidinofenylalaninderivater, samt fremstilling, anvendelse og preparater inneholdende forbindelsene
SE8904298D0 (sv) New compounds
ES2185666T3 (es) Formulacion estabilizada para comprimidos.
YU10599A (sh) Amorfni benzotiofeni, postupak dobijanja istih i njihova farmaceutska formulacija
SE9504662D0 (sv) New compounds
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
FI923751A (fi) Hexahydrobenso/f/kinolinoner